Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Noncontrolling Interest
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019   19,410,000      
Beginning balance at Dec. 31, 2019 $ 129,436 $ 135,741 $ 4,693 $ 227 $ (11,225)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 394 $ 394      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   60,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (159) $ (159)      
Net income 3,006   2,962 44  
Other comprehensive loss (109)       (109)
Ending balance (in shares) at Mar. 31, 2020   19,470,000      
Ending balance at Mar. 31, 2020 $ 132,568 $ 135,976 7,655 271 (11,334)
Beginning balance (in shares) at Dec. 31, 2020 19,697,000 19,697,000      
Beginning balance at Dec. 31, 2020 $ 157,234 $ 139,311 26,030 1,848 (9,955)
Increase (Decrease) in Shareholders' Equity          
Share-based compensation expense 1,005 $ 1,005      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)   218,000      
Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (914) $ (914)      
Cash dividends (19,858)   (19,858)    
Net income 4,152   4,016 136  
Other comprehensive loss $ (121)       (121)
Ending balance (in shares) at Mar. 31, 2021 19,915,000 19,915,000      
Ending balance at Mar. 31, 2021 $ 141,498 $ 139,402 $ 10,188 $ 1,984 $ (10,076)